Intrinsic4D Software Adopted by Five Leading Insurance Companies

TORONTO, ONTARIO--(Marketwired - Dec. 10, 2015) - Intrinsic4D Inc. ("Intrinsic4D") (TSX VENTURE:IFD) is pleased to announce that five of the top 25 U.S. casualty insurance companies (Click here to view source) are now using Intrinsic4D's medical-legal service, Authentic4D, to facilitate earlier resolution of casualty claims.

"The Authentic4D solution is able to convert standard medical images into a powerful full motion 3D video through our proprietary software for a fraction of the cost and time compared to traditional methods," said Jorey Chernett, CEO of Intrinsic4D. "As anticipated, the response from the insurance industry has been quick and extremely positive."

Chernett continued to say, "Nearly 70% of human beings are visual learners, yet most cannot understand how to read a black and white medical image. Invariably the process of resolving a casualty claim can be prolonged due to a general lack of trust that exists between insurance carriers and plaintiff attorneys. The result is substantially higher litigation costs and lost productivity. The Authentic4D service addresses this objectively through our proprietary and FDA cleared platform that translates any standard MRI or CT scan into an affordable and easy-to-understand tour of the actual anatomy in 3D that is accompanied by a radiologist affidavit with an admissibility guarantee."

Intrinsic4D believes its Authentic4D service will change the landscape of the insurance industry, resulting in earlier claim resolution and significant financial savings for its clients.

About Intrinsic4D Inc.

Intrinsic4D, through its Authentic brand, is the developer of the patented and FDA- cleared transformative software-as-a-service medical platform servicing the medical-legal industry. Through its patented and disruptive Stenosis Severity Mapping (SSM) Cardio solution, it aims to reduce the $13 billion of unnecessary cardiac catheterizations performed annually, which are attributed to false positive reads of diagnostic tests for evaluating coronary artery disease.

Disclaimer for Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information may relate to the Corporation's future outlook and anticipated events or results.. Particularly, statements regarding future results, performance, achievements and prospects or opportunities for the Corporation are forward looking statements. Some of the specific forward looking statements in this press release include, but are not limited to, statements with respect to the potential for the Authentic4D service resulting in earlier claim resolution and significant financial savings for insurance industry clients. Although the forward-looking statements contained in this press release are based upon assumptions that management of the Corporation believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Corporation's control, which may cause actual results to differ materially from those expressed or implied by such forward-looking statements. The forward-looking statements made in this press release relate only to events or information as of the date hereof. Except as required by applicable law, the Corporation undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.